why choose us

First received: July 26, 2023

Clinical Trial: Safety and Efficacy of Venetoclax in Idiopathic Pulmonary Fibrosis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Idiopathic Pulmonary Fibrosis

Study Type: INTERVENTIONAL


Official Title: Safety and Efficacy of Venetoclax in Idiopathic Pulmonary Fibrosis

Brief Summary: Based on preclinical data, investigators hypothesize that apoptosis resistance in monocyte-derived macrophages (MDMs) have a decisive role in the development of idiopathic pulmonary fibrosis (IPF).Specifically, macrophages from subjects with IPF have increased expression of Bcl-2 in mitochondria.In preclinical models of IPF, a conditional deletion of Bcl-2 in MDMs reverses established fibrosis by inducing apoptosis.Additional evidence to suggest that Bcl-2 expression in MDM mitochondria is a therapeutic target for…

Read more